IL25 and asthma: They found that anti-IL-25 monoclonal antibody (LNR125) treatment increased the RV load in an asthma model established by BALB/c, while they did not observe any changes in coronavirus 229E and RV viral load with LNR125 treatment in bronchial epithelial cells (BECs), which implied that ovalbumin established asthma BALB/c mouse model led to a different role for IL-25 in viral infections.